Connection
Matthew J. Brady to Phosphatidylinositol 3-Kinase
This is a "connection" page, showing publications Matthew J. Brady has written about Phosphatidylinositol 3-Kinase.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.120 |
|
|
|
-
Sargis RM, Neel BA, Brock CO, Lin Y, Hickey AT, Carlton DA, Brady MJ. The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels. Biochim Biophys Acta. 2012 Jun; 1822(6):952-60.
Score: 0.120